Apply knowledge of excipients, preformulation studies, stability formulation of pharmaceutical products and drug delivery systems.

Similar documents
Section-I PHARMACEUTICAL ENGINEERING II PH221. Course Code. Lecture : 3. Practical : 2. Course Credit. Tutorial : 0. Total : 5.

The University of Jordan

The University of Jordan. Pharmaceutical Technology II ( ) Office number . Office hours Day/Time Sunday Monday Tuesday Wednesday Thursday

FACULTY OF PHARMACY. M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques

INSTRUMENTAL ANALYSIS-I

OMICS International Conferences

PHARMACEUTICAL BULLETINS

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Course. No. No. asu.edu.jo

PHRC 4110 Pharmaceutics I

B.E. (Civil) Semester: V Subject Name: GEOTECHNICAL ENGINEERING-I (CV503)

Compounding. Course Design hours lecture per week or 32 total hours Transfer Status

Formulation and in vitro evaluation of candesartan liquid solid compacts to enhance drug solubility

Bachelor of Technology Civil Engineering. 01CI0301: Mechanics of Solids

PART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS.

Importance Of Accelerated Stability Study

LESSON PLAN-1 T1-Session

Design and development of fast dissolving tablets containing ziprasidone by solid dispersion method

Opportunities for Regulatory Relief via In Vitro Dissolution. James E. Polli June 10, 2015

Study of processing parameters affecting dissolution profile of highly water soluble drug

Impact factor: /ICV: PROCESS VALIDATION OF PARACETAMOL SUSPENSION Sisal Shah*, Dinesh G. Desai, A. K.

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

International Journal of Advanced Chemical Science and Applications (IJACSA)

Formulation and in-vitro evaluation of sustained release matrix tablets of gliclazide

Medicinal Chemistry 1

King Saud University College of Pharmacy Department of Pharmaceutics. Biopharmaceutics PHT 414. Laboratory Assignments 2010 G 1431 H

CDER Risk Assessment to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products

Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D

Stability of pharmaceutical preparations

TABLE OF CONTENTS. vii

Innovations in Pharmaceuticals and Pharmacotherapy. Original Article Formulation and evaluation of diclofenac sodium effervescent tablet

PREFORMULATION STUDY ON THE GUM OF MORINGA OLEIFERA

22 Oral Solid Dosage Forms Chapter Objectives At the conclusion of this chapter the student should be able to:

Pharmaceutics and Pharmaceutical Technology

Course Specification Medicinal Chemistry-1

Instrumental Chemical Analysis

A REVIEW ON PHARMACEUTICAL PREFORMULATION STUDIES IN FORMULATION AND DEVELOPMENT OF NEW DRUG MOLECULES

PREFORMULATION STUDIES IN DRUG DESIGN

Preparation and Evaluation of Directly Compressible Forms of Mutual Prodrugs of Ibuprofen

Materials for Pharmaceutical Manufacturing

THE INTRODUCTION OF PROCESS ANALYTICAL TECHNOLOGY, USING NEAR INFRARED ANALYSIS, TO A PHARMACEUTICAL BLENDING PROCESS

Available online through ISSN

IVIVC Industry Perspective with Illustrative Examples

Development of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations

295 J App Pharm 03(03): (2011) Nayak et al., 2011 COMPARATIVE STABILITY STUDY OF METRONIDAZOLE IN AQUEOUS AND NON AQUEOUS VEHICLE

SOLID DISPERSION OF POORLY WATER SOLUBLE DRUGS EARLY PROMISES SUBSEQUENT ELECTROSPUN AMORPHOUS SOLID DISPERSIONS OF POORLY WATER

EASTERN ARIZONA COLLEGE Sterile Products and Compounding

Application of Arrhenius Equation and Plackett-Burman Design to Ascorbic Acid Syrup Development

S.Janakidevi et al. Int. Res. J. Pharm. 2014, 5 (7) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Part ONE. Answer ALL questions. For each questions, there is ONE correct answer. Use the multiple choice reader card provided for ALL your answers.

Physical Final Exam

Quality by design (QbD) is an intelligent

Factors Affecting IVIVC

Powder. Aulton Chapter 8-10,14,24. Powders

Formulation and evaluation of matrix tablets of Famotidine using hydrophilic polymer

Course Specification

Syllabus of M.Pharm. I Sem. under CBCS

WHITE PAPER ENSURING CONSISTENCY IN POLYMORPHIC DRUG SUBSTANCES AND PRODUCTS: When and How to Apply a Specification Limit

Fasted State Dissolution Protocol

International Journal of Innovative Pharmaceutical Sciences and Research

BIO & PHARMA ANALYTICAL TECHNIQUES. Chapter 5 Particle Size Analysis

Technical brochure DuraLac H TABLETING DIRECT COMPRESSION ANHYDROUS LACTOSE

Formulation and evaluation of sustained release matrix tablets of nifedipine

KING KHALID UNIVERSITY

Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP

Statistics and modeling in in vitro release studies

EFFECT OF VARIOUS ENVIRONMENTAL /PROCESSING FACTORS ON STABILITY OF THE FORMULATION AND TECHNIQUES FOR STABILIZATION OF PRODUCTS AGAINST THE SAME.

Overview. Lecture 5 Colloidal Dispersions

Journal home page:

Polymorphism A Critical Consideration in Pharmaceutical Development, Manufacturing, and Stability

Particle size and shape influence the production of solid dosage forms. This study aimed to use the three shape

Impact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets

FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRAING TABLET OF CIMITIDINE HCL

Pharmaceutical Characterisation. Dr. Lidia Tajber and Dr. Krzysztof Paluch School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin

Setting Attainable and Practical Particle Size Specifications

International Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research

A Review on Polymorphism Perpetuates Pharmaceuticals

Drug is any chemical entities intended to

Physical-Chemistry Factors Affecting Oral Absorption. Objectives. ph - Partition Theory. 27 September Chapter 23 1

Mishra Sruti Ranjan et al. IRJP 2 (8)

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

Syllabus: PHARMACEUTICAL CHEMISTRY Ι. Code number: 48 Cycle: Undergraduate Semester: 5th semester. Course type

Determination of Design Space for Oral Pharmaceutical Drugs

CHAPTER VIII 8. DEVELOPMENT OF A TOPICAL HERBAL FORMULATION WITH THE FRACTION

In Vivo Predictive Dissolution Flux Measurements. Konstantin Tsinman, PhD Chief Scientific Officer Pion Inc

Scholars Research Library

PRACTICAL APPROACH FOR THE ESTIMATION OF ALCOHOL DRUG RELEASE FROM THE SUSTAINED RELEASE DOSAGE FORMS OF VERAPAMIL HYDROCHLORIDE

FORMULATION AND EVALUATION OF PIROXICAM LIQUISOLID COMPACTS

Formulation and evaluation of suspensions: Mefenamic acid prodrugs

Research Article. Development of Controlled Release Tablets of Nisoldipine with Improved Pharmaceutical Properties

Scholars Research Library

Formulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps

Preparation and Evaluation of Matrix Tablets Containing Ambroxol Hydrochloride

Integrated study of Pharmacy. 2 nd

Polymorphism. Solid State Stability. Seminar overview

Christin T. Choma TA Instruments, 109 Lukens Drive, New Castle, DE 19720, USA

Pelagia Research Library

OF POLYMER MODIFIEDCRYSTALS

Formulation and Evaluation of Immediate Release Tablets of Nevirapine Solid Dispersions

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Transcription:

Course Title Course Code DOSAGE FORM DESIGN PH702 Lecture : 3 Course Credit Practical : 3 Tutorial : 0 Total : 6 Course Objectives On the completion of the course, students will be able to: Apply knowledge of excipients, preformulation studies, stability formulation of pharmaceutical products and drug delivery systems. evaluation in the To integrate aspects of preformulation, stability requirements, dissolution study, and validation for the development of Pharmaceutical Dosage Forms. Detailed Syllabus Sr. No. Name of Chapter & Details Hours Allotted Section-I 1 Physico-chemical Characterization: 14 Study of physical properties of drug like physical form, particle size, shape, density, crystallinity, hygroscopicity, wetting, dielectric constant,

solubility, dissolution and organoleptic property and their effect on formulation, stability and bioavailability. Rationale for selecting the preferred polymorph/crystalline form. Degradation Pathways: Study of chemical properties of drugs like hydrolysis, oxidation, reduction, polymorphisms, racemization, polymerization etc., and their influence on formulation and stability of products. Study of prodrugs in solving problems related to stability, bioavailability and elegance of formulations. Drug-excipient compatibility studies and its importance in pharmaceutical development. Traces of organic volatile impurities (OVIs) and their regulatory limits (residual solvents). 2 Introduction to BCS and dissolution study: Definition, Importance and objectives of dissolution, Dissolution mechanisms, Factors affecting dissolution, Intrinsic dissolution rate measurement, Dissolution apparatus for various dosage forms, Selection of dissolution media and conditions, Dissolution profile comparison methods, biowaiver. Biological classification system (BCS); its significance on dissolution study and application in dosage form development. 09 Section-II 3 Basics of IVIVR and IVIVC: Methods of establishing IVIVC, Factors affecting IVIVC, Biorelevant Dissolution Medium. 04

4 Stability of pharmaceuticals: Kinetic principles and stability testing: Reaction rate and order, acid base catalysis, decomposition reactions and stabilization of pharmaceuticals, Effect of various environmental/ processing factors like light, ph, temperature, etc. on stability of the formulation and techniques for stabilization of product against the same, Stability of formulation, MKT, climatic zones, matrixing and bracketing in stability study, accelerated stability testing, real time stability. Current WHO, USFDA and stability testing as per ICH guidelines for pharmaceutical drug substances and drug products. Shelf-life, Overages, Overage calculations. 12 5 Efffect of following adjavunts on formulation of different pharmaceutical products: Antioxidants, preservatives, colours, flavours, diluents, binders, disintigrants, antifictional agents, emulsifiers, suspending agents, solvents etc. and other formulation additives. 06 Dosage Form Design (Practical) 1. Determination of the angle of repose, Carr s index, Hausner s ratio of given powder/ granules. 2. Determination of solubility of given drug at different ph. 3. To study the compression characteristic of different diluents. 4. To study the effect of various binders on performance of tablet. 5. To study the effect of various disintigrants on performance of tablet. 6. To study the Influence of temperature on the stability of aspirin/ ascorbic acid solution. 7. Compendial dissolution testing and data evaluation for given tablets and capsules. 8. In-vitro dissolution profile comparison of given tablet with reference product using similarity and dissimilarity factor. 9. Enhancement of solubility of poorly water soluble drug by solid dispersion. 10. Enhancement of solubility of poorly water soluble drug by -Cyclodextrin complexation.

11. Preformulation studies including drug-excipient compatibility studies. 12. Calculation of bioavailability parameters from the given pattern of drug absorption from oral & IV formulations. 13. Other practicals covering syllabus aspects. Instructional Method and Pedagogy: Lectures will be conducted with the aid of multi-media projector, black board, OHP etc. Assignments based on course content will be given to the students at the end of each unit/topic and will be evaluated at regular interval. Surprise tests/quizzes/seminar/tutorials will be conducted. The course includes a laboratory, where students have an opportunity to build an appreciation for the concepts being taught in lectures. Students Learning Outcomes: By the end of this course, the student should have a good understanding of basic process which are used in different stage during preparation of pharmaceutical formulation. Students should be able to know calculation of formulas, labeling, and packing of different types of pharmaceutical products. Text Books: 1. Pharmaceutical Dosage Forms and Drug Delivery Systems by Ansel & others. 2. Pharmaceutical Technology by Sambamurthy, New Age publication.

Reference Books: 1. The Science & Practice of Pharmacy: A. G. Remington; Lippincott, Philadelphia. 2. Pharmaceutical Dosage Forms: Tablets: Vol.1, Vol. 2 and Vol.3, Ed. by Lieberman, Leon Lachman and Joseph B. Schwartz, Marcel Dekker Inc., New York. 3. Modern Pharmaceutics by Gilbert S. Banker and Christopher T. Rhodes, Marcel Dekker, Inc., New York. 4. Stability of drug and dosage forms by Yoskioka, BSP publication. 5. Drug stability (Principles and Practices) by Jens. T. Carstensen, Marcel Dekker. 6. Pharmaceutical Preformulation by carstensen, CRC publication. 7. Pharmaceutical Dissolution Testing by Dressman and Jennifer, Informa publication. 8. Pharmaceutical dissolution testing by Umesh V. Banker, Marcel Dekker Inc. Additional Resources Soft copies of dosage form design books are available on http://www.pharmatext.org, www.pharmacyebooks.com, and in www.pharmamirror.com. Latest information regarding dosage form design are available on http://www.pharmainfo.net Study material of dosage form design are available on mypharmaguide.com, pharmatutor.com, authorstream.com, slideworld.com and in scribd.com. Review articles published in international journal covering syllabus aspect.